Management of Traumatic Brain Injury Sequelae With Alpha-2 Adrenergic Receptor Agonists
This class of medication has a number of different indications (and side effects), and drugs within this class also have some unique properties that can be important factors in clinical decision-making. Although this class of medications has been available for many years, there is still much emerging information that is pertinent for the treatment of patients with TBI.
Authors
- Thomas K. Watanabe (ORCID: https://orcid.org/0000-0001-8378-0847)
- Jamie Ott (ORCID: https://orcid.org/0000-0003-1450-2530)
Institutions
- Office of Technology Transfer (US)
- Watanabe Applied Technology (Brazil) (BR)
- Moss Rehabilitation Hospital (US)
Publication Details
- Journal
- Journal of Head Trauma Rehabilitation
- Published
- 2025-08-22
- DOI
- https://doi.org/10.1097/htr.0000000000001099
- Primary Topic
- Traumatic Brain Injury and Neurovascular Disturbances
- Type
- article
- Field-Weighted Citation Impact
- 0.00